Ordinary Rebalance | Solactive Sustainable Health and Wellness Index | Effective Date 12th December 2023
In the ordinary rebalance, the following composition will be implemented effective open 12.12.2023:
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
BIONTECH SE |
EISAI |
OMRON CORP ORD |
NIHON KOHDEN CORP ORD |
CANON INC |
ABBVIE INC |
ABBOTT LABORATORIES |
ADAPTIVE BIOTECHNOLOGIES CORP |
ADIDAS AG |
ADAPTHEALTH CORP |
ALECTOR INC |
ALLOGENE THERAPEUTICS INC |
AMEDISYS INC |
ASTRAZENECA PLC |
BAYER AG |
BEAM THERAPEUTICS INC |
BIOGEN INC |
BRISTOL-MYERS SQUIBB CO |
BOSTON SCIENTIFIC CORP |
CONMED CORP |
COCHLEAR LTD |
CARIBOU BIOSCIENCES INC |
CRISPR THERAPEUTICS AG |
COMMUNITY HEALTH SYSTEMS INC |
DOCGO INC |
DEMANT A/S |
DOXIMITY INC-CLASS A |
DEXCOM INC |
EBOS GROUP LTD |
EDITAS MEDICINE INC |
ELEVANCE HEALTH INC |
ECKERT & ZIEGLER STRAHLEN UND MEDIZINTECHNIK AG |
EDWARDS LIFESCIENCES CORP |
FATE THERAPEUTICS INC |
FLUIDRA SA |
GILEAD SCIENCES INC |
GLOBUS MEDICAL INC |
GN STORE NORD A/S |
GARMIN LTD |
HCA HEALTHCARE INC |
HEALTHCARE SERVICES GROUP |
HOLOGIC INC |
IDEXX LABORATORIES INC |
ILLUMINA INC |
INOGEN INC |
IRHYTHM TECHNOLOGIES INC |
INTUITIVE SURGICAL INC |
ELI LILLY & CO |
LONZA GROUP AG |
MASIMO CORPORATION |
MEDTRONIC PLC |
MERCK & CO. INC. |
MODERNA INC |
MAXCYTE INC |
NOVARTIS AG |
NOVO NORDISK A/S |
INTELLIA THERAPEUTICS INC |
NOVOCURE LTD |
OPTIMIZERX CORP |
L OREAL SA |
PFIZER INC |
PLANET FITNESS INC – CL A |
PRO MEDICUS LTD |
INSULET CORP |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROCHE HOLDING AG |
LABORATORIOS FARMACEUTICOS R |
SANOFI SA |
SEAGEN INC |
SANGAMO THERAPEUTICS INC |
SONIC HEALTHCARE (TECH AUST) ORD |
SIEMENS HEALTHINEERS AG |
SMITH & NEPHEW PLC |
SLEEP NUMBER CORP |
SONOVA HOLDING AG |
STRYKER CORP |
TECHNOGYM SPA |
TENET HEALTHCARE CORP |
THERMO FISHER SCIENTIFIC INC |
TANDEM DIABETES CARE INC |
UDEMY INC |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |